Response Rate as a Potential Surrogate for Survival and Efficacy in Patients Treated With Novel Immune Checkpoint Inhibitors: A Meta-Regression of Randomised Prospective Studies

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2017.09.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Gene Expression Profiling Identified TP53MutPIK3CAWild as a Potential Biomarker for Patients With Triple‑negative Breast Cancer Treated With Immune Checkpoint Inhibitors

Oncology Letters
Cancer ResearchOncology
2020English

Evaluation of Classical Clinical Endpoints as Surrogates for Overall Survival in Patients Treated With Immune Checkpoint Blockers: A Systematic Review and Meta-Analysis

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2018English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Workup and Management of Immune‐Mediated Colitis in Patients Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data

International Journal of Cancer
Cancer ResearchOncology
2017English

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer Research
MedicineCancer ResearchOncology
2020English

Angiosarcoma Patients Treated With Immune Checkpoint Inhibitors: A Case Series of Seven Patients From a Single Institution

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy